This study was undertaken to evaluate the feasibility, safety and efficacy of a new combined single-step therapy in patients with unresectable multinodular unilobar hepatocellular carcinoma (HCC), with at least one lesion >3 cm, with balloon-occluded radiofrequency ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE) of the main lesion and TACE of the other lesions. The second purpose of our study was to compare the initial effects in terms of tumour necrosis of this new combined therapy with those obtained in a matched population treated with TACE alone in a singlestep treatment in our centre in the previous year.
Iezzi, R., Cesario, V., Siciliani, L., Campanale, M., De Gaetano, A. M., Siciliano, M., Agnes, S., Giuliante, F., Grieco, A., Pompili, M., Rapaccini, G. L., Gasbarrini, A., Bonomo, L., Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE), <<LA RADIOLOGIA MEDICA>>, 2013; 118 (4): 555-569. [doi:10.1007/s11547-012-0914-7] [http://hdl.handle.net/10807/60744]
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE)
Iezzi, Roberto;Cesario, Valentina;Siciliani, Luisa;Campanale, Mariachiara;De Gaetano, Anna Maria;Siciliano, Massimo;Agnes, Salvatore;Giuliante, Felice;Grieco, Antonio;Pompili, Maurizio;Rapaccini, Gian Ludovico;Gasbarrini, Antonio;Bonomo, Lorenzo
2013
Abstract
This study was undertaken to evaluate the feasibility, safety and efficacy of a new combined single-step therapy in patients with unresectable multinodular unilobar hepatocellular carcinoma (HCC), with at least one lesion >3 cm, with balloon-occluded radiofrequency ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE) of the main lesion and TACE of the other lesions. The second purpose of our study was to compare the initial effects in terms of tumour necrosis of this new combined therapy with those obtained in a matched population treated with TACE alone in a singlestep treatment in our centre in the previous year.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
